Neurogene Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

NGNE

organization

SIC: 2834

SEC Insider

$184.2M

536 transactions

Summary

Neurogene Inc. (NGNE) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $138.2MSales: $44.4M50 insiders

Date	Insider	Type	Value
2026-05-06	Cvijic Christine Mikail(President and CFO)	Sell	$156K
2026-05-06	Cvijic Christine Mikail(President and CFO)	Sell	$144K
2026-02-27	Cvijic Christine Mikail(President and CFO)	Sell	$121K
2026-03-13	Cobb Stuart(Chief Scientific Officer)	Sell	$81K
2026-03-26	McMinn Rachel(Chief Executive Officer)	Sell	$74K
2026-03-13	Cobb Stuart(Chief Scientific Officer)	Sell	$57K
2026-03-26	Cvijic Christine Mikail(President and CFO)	Sell	$55K
2026-03-13	Cvijic Christine Mikail(President and CFO)	Sell	$49K
2026-03-13	Cvijic Christine Mikail(President and CFO)	Sell	$30K
2026-03-26	Jordan Julie(Chief Medical Officer)	Sell	$18K
2026-03-13	Cvijic Christine Mikail(President and CFO)	Sell	$6K
2026-03-13	Cobb Stuart(Chief Scientific Officer)	Sell	$3K
2026-05-05	Shafer Christina(Chief Commercial Officer)	A	$0
2026-02-20	BAFFI ROBERT	A	$0
2026-02-20	Cvijic Christine Mikail(President and CFO)	A	$0
2026-02-20	Cvijic Christine Mikail(President and CFO)	A	$0
2026-02-20	McMinn Rachel(Chief Executive Officer)	A	$0
2026-02-20	McMinn Rachel(Chief Executive Officer)	A	$0
2026-02-20	PALEKAR ROHAN	A	$0
2026-02-20	Noonberg Sarah B.	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Neurogene Inc. — Contributions, Lobbying & Contracts | Poliscope